RVMD

Revolution Medicines Inc.

Price

$205.55

return (12m)

492.36%

p/e

-23.75

p/bv

16.11

DIVIDEND YIELD

0.00%

RVMD price

Revolution Medicines

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RVMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.82%

3 months

37.09%

1 year

492.36%

2 years

379.14%

5 years

758.25%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals RVMD

Valuation

P/E

-23.75

Sector -4.25

Industry -4.25

P/BV

16.11

Sector 2.05

Industry 2.05

P/Revenue (PSR)

Sector -4.32

Industry -4.32

EV/EBITDA

-63.02

Sector -223.70

Industry -223.70

EV/EBIT

-62.11

Sector -658.37

Industry -658.37

P/EBITDA

-24.90

Sector -4.42

Industry -4.42

P/EBIT

-24.57

Sector -4.65

Industry -4.65

P/Total Assets

9.71

Sector 1.48

Industry 1.48

P/Net Current Assets

18.17

Sector -11.90

Industry -11.90

P/Working Capital

11.43

Sector -12.45

Industry -12.45

EPS

-8.38

Sector -2.19

Industry -2.19

BVPS

12.35

Sector 1.87

Industry 1.87

Efficiency

Gross Margin

0.00%

Sector 36.35%

Industry 36.35%

EBITDA Margin

Sector -16,780.87%

Industry -16,780.87%

EBIT Margin

Sector -4,293,432.86%

Industry -4,293,432.86%

Operating Margin

0.00%

Sector -38.73%

Industry -38.73%

Net Profit Margins

0.00%

Sector -39.98%

Industry -39.98%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-67.85%

Sector -67.22%

Industry -67.22%

ROA

-40.90%

Sector -66.45%

Industry -66.45%

ROIC

-568.79%

Sector -2,064.28%

Industry -2,064.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

11.38

Sector 2.89

Industry 2.89

Net Debt / EBITDA

5.64

Sector -13,956,095.71

Industry -13,956,095.71

Net Debt / EBIT

5.56

Sector -7.72

Industry -7.72

Net Debt / Equity

-1.32

Sector -1.09

Industry -1.09

Gross Debt / Equity

0.19

Sector -0.07

Industry -0.07

Equity/Assets

0.60

Sector 0.41

Industry 0.41

Liabilities/Assets

0.40

Sector 0.40

Industry 0.40

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

56.71%

Sector -

Industry -

Fundamentals RVMD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RVMD Revolution Medicines Inc.	$205.55	487.29%	0.00%	-23.75	16.11	-67.85%	0.00%
JNJ Johnson & Johnson	$259.80	54.01%	2.05%	29.23	7.24	24.76%	21.48%
PFE Pfizer Inc.	$26.62	17.93%	6.61%	34.22	1.73	5.07%	6.80%
ABBV AbbVie Inc.	$249.93	30.95%	2.72%	69.54	-74.01	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.17	0.58%	4.00%	11.36	6.03	53.11%	35.32%
MRK Merck & Co. Inc.	$130.42	68.08%	2.63%	99.31	0.00	-%	4.77%
AZN AstraZeneca PLC	$158.75	7.88%	2.01%	23.71	4.92	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$63.61	45.00%	3.91%	14.14	5.88	41.59%	18.87%
ZTS Zoetis Inc.	$75.35	-47.71%	2.81%	11.73	9.74	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$797.00	43.99%	0.47%	18.55	2.53	13.65%	27.86%
AMGN Amgen Inc.	$414.30	49.01%	2.43%	24.89	18.62	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$102.62	63.15%	0.00%	28.46	82.01	288.14%	24.86%
MCK McKesson Corporation	$901.77	35.57%	0.37%	22.83	-80.58	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$529.65	44.50%	0.00%	28.28	6.15	21.76%	35.00%
CAH Cardinal Health Inc.	$240.26	54.24%	0.86%	36.08	-21.00	-58.20%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.52	15.59%	0.00%	12.41	2.25	18.14%	18.89%
BIIB Biogen Inc.	$203.89	56.03%	0.00%	36.48	1.62	4.43%	8.32%
MEDP Medpace Holdings Inc.	$605.50	39.40%	0.00%	33.22	37.63	113.29%	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RVMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Revolution Medicines

Revolution Medicines Inc.

Average Investor10 user rating

4.0 (4 people)

United States

12 years

Founded: 2014

2020

Time since IPO - 6 years

125

Employees

Revolution Medicines Inc. (United States) is listed on the Nasdaq and has a market capitalization of $41.99 billion, with shareholders equity totaling $2.61 billion.

The company employs approximately 125 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Revolution Medicines Inc. reported $- in revenue, generating net income of $-1.77 billion.

Key financial metrics include a P/E ratio of -23.75, a price-to-book (P/B) ratio of 16.11, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RVMD.

Market cap

$41.99 billion

Net worth

$2.61 billion

$2,606,240,000.00

Assets

$4.32 billion

$4,323,270,000.00

Total Shares Outstanding

211.00 million

211,000,000

Average Daily Trading Volume

$2.74 million

$2,738,230.00

Sector

Health Care

Industry

Biotechnology

RVMD

RVMD revenue and profits

Financial Results RVMD

DRAG THE FRAME TO SEE MORE DATA

RVMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$901.77 37,54% (12M)

P/E

22.83

0.37%

ROE

-352.96%

P/BV

-80.58

CAH - Cardinal Health

$240.26 65,95% (12M)

P/E

36.08

0.86%

ROE

-58.20%

P/BV

-21.00

JNJ - Johnson & Johnson

$259.80 54,94% (12M)

P/E

29.23

2.05%

ROE

24.76%

P/BV

7.24

ABBV - AbbVie

$249.93 30,95% (12M)

P/E

69.54

2.72%

ROE

-106.44%

P/BV

-74.01

MRK - Merck & Co.

$130.42 68,90% (12M)

P/E

99.31

2.63%

ROE

P/BV

0.00

AZN - AstraZeneca

$158.75 4,28% (12M)

P/E

23.71

2.01%

ROE

20.74%

P/BV

4.92

PFE - Pfizer

$26.62 17,59% (12M)

P/E

34.22

6.61%

ROE

5.07%

P/BV

1.73

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$901.77 37,54% (12 M)

P/L

22.83

0.37%

ROE

-352.96%

P/VP

-80.58

CAH - Cardinal Health

$240.26 65,95% (12 M)

P/L

36.08

0.86%

ROE

-58.20%

P/VP

-21.00

JNJ - Johnson & Johnson

$259.80 54,94% (12 M)

P/L

29.23

2.05%

ROE

24.76%

P/VP

7.24

ABBV - AbbVie

$249.93 30,95% (12 M)

P/L

69.54

2.72%

ROE

-106.44%

P/VP

-74.01

MRK - Merck & Co.

$130.42 68,90% (12 M)

P/L

99.31

2.63%

ROE

P/VP

0.00

AZN - AstraZeneca

$158.75 4,28% (12 M)

P/L

23.71

2.01%

ROE

20.74%

P/VP

4.92

PFE - Pfizer

$26.62 17,59% (12 M)

P/L

34.22

6.61%

ROE

5.07%

P/VP

1.73

Frequently Asked Questions

What is the price of Revolution Medicines (RVMD) today?

A cotação de Revolution Medicines (RVMD) hoje está em US$ 205.55, com uma variação de 492.36% em relação ao último ano. A cotação de Revolution Medicines (RVMD) iniciou o ano negociando na casa dos US$ 79.65 e hoje está em US$ 205.55. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Revolution Medicines (RVMD) e dados de ações do Ibovespa e mercados internacionais.

Quando Revolution Medicines (RVMD) paga dividendos?

Revolution Medicines (RVMD) não distribuiu dividendos no último ano.

Is Revolution Medicines (RVMD) a good investment?

Atualmente, Revolution Medicines (RVMD) está cotada a US$ 205.55, com um P/L de -23.75, representando um desvio de -1,356% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 492.36 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 492.36%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Revolution Medicines (RVMD) stock?

Investir em ações de Revolution Medicines (RVMD) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Revolution Medicines (RVMD) yield today?

A rentabilidade de Revolution Medicines (RVMD) foi de 12.82% no último mês, 492.36% no último ano e 758.25% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Revolution Medicines (RVMD) hoje, o investimento total seria de US$ 20,555.00, com base na cotação atual de US$ 205.55.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 121,759.60
Em 5 anos: US$ 176,413.29
Em 10 anos: US$ 20,555.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RVMD

Revolution Medicines Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RVMD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RVMD WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Revolution Medicines

Revolution Medicines Inc.

United States

12 years

2020

125

PROFIT X PRICE RVMD

Financial Results RVMD

RVMD cash flow

Asset, Revenue and Profit Growth - RVMD

RVMD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions